Menu
Back to Journals » OncoTargets and Therapy » Volume 8
Original Research
Axitinib versus sorafenib as a second-line therapy in Asian patients with metastatic renal cell carcinoma: results from a randomized registrational study
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 14,533 | Dovepress* | 12,833+ | 1,572 | 14,405 | |
| PubMed Central* | 1,700 | 660 | 2,360 | ||
| Totals | 14,533 | 2,232 | 16,765 | ||
|
*Since 8 June 2015 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 2 |
View citations on PubMed Central and Google Scholar